HomeGRCE • NASDAQ
add
Grace Therapeutics, Inc
Previous close
$2.99
Day range
$2.92 - $3.01
Year range
$1.75 - $4.97
Market cap
40.66M USD
Avg Volume
41.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.18M | -0.69% |
Net income | 636.00K | 120.09% |
Net profit margin | — | — |
Earnings per share | 0.14 | 138.52% |
EBITDA | -3.18M | 0.72% |
Effective tax rate | 266.49% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.13M | -3.79% |
Total assets | 71.99M | -1.78% |
Total liabilities | 5.38M | -53.42% |
Total equity | 66.61M | — |
Shares outstanding | 13.83M | — |
Price to book | 0.61 | — |
Return on assets | -11.95% | — |
Return on capital | -13.40% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 636.00K | 120.09% |
Cash from operations | -2.95M | -41.48% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 14.03M | — |
Net change in cash | 11.08M | 148.39% |
Free cash flow | -2.32M | -112.74% |
About
Founded
2002
Website
Employees
32
